Stuart Holden, MD

Director, Louis Warschaw Prostate Cancer
Warschaw, Robertson, Law Families Chair in Prostate Cancer


Stuart Holden, MD is the Director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai. He also holds the Warschaw, Robertson, Law Families Chair in Prostate Cancer. A specialist in urological oncology, Dr. Holden has been an attending surgeon at Cedars-Sinai Medical Center and a clinical assistant professor of Surgery (Urology) at the University of California, Los Angeles (UCLA).

Dr. Holden has been appointed to several administrative positions at Cedars-Sinai, including serving as Clinical Chief of the Division of Urology, Co-Chairman of the Cancer Committee and, currently, as Chairman of the Operating Room Advisory Committee. Prior to joining Cedars-Sinai in 1978, Dr. Holden was Assistant Professor of Surgery (Urology) at Georgetown University School of Medicine.

Dr. Holden is the principal investigator on several clinical studies involving new pharmaceutical treatments for prostate cancer. Dr. Holden has also served as Medical Director of the Prostate Cancer Foundation (CaP CURE), the largest private funder of prostate cancer research in the world, since 1993. He is a member of several professional societies and has been active in organizations such as the American Cancer Society and the Prostate Cancer Research Project for the Department of Defense.

Dr. Holden received his bachelor's degree in philosophy at the University of Wisconsin and a medical degree from New York Hospital Cornell University Medical College. He completed a surgical internship and residency at New York Hospital Cornell University Medical Center and residency in urology at Emory University. At the Memorial-Sloan Kettering Cancer Center he completed two fellowships, one in urology and one in developmental genetics. During this period, he was awarded a clinical fellowship from the American Cancer Society.